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Comparative study of the effects of
different radiation qualities on normal
human breast cells
Dajana Juerß1*†, Monique Zwar1†, Ulrich Giesen2, Ralf Nolte2, Stephan Kriesen1, Giorgio Baiocco3,
Monika Puchalska4, Marc-Jan van Goethem5, Katrin Manda1 and Guido Hildebrandt1
Abstract
Background: As there is a growing number of long-term cancer survivors, the incidence of carcinogenesis as a late
effect of radiotherapy is getting more and more into the focus. The risk for the development of secondary
malignant neoplasms might be significantly increased due to exposure of healthy tissue outside of the target field
to secondary neutrons, in particular in proton therapy. Thus far, the radiobiological effects of these neutrons and a
comparison with photons on normal breast cells have not been sufficiently characterised.
Methods: MCF10A cells were irradiated with doses of up to 2 Gy with neutrons of different energy spectra and
X-rays for comparison. The biological effects of neutrons with a broad energy distribution (<En > = 5.8 MeV),
monoenergetic neutrons (1.2 MeV, 0.56 MeV) and of the mixed field of gamma’s and secondary neutrons (<En > =
70.5 MeV) produced by 190 MeV protons impinging on a water phantom, were analysed. The clonogenic survival
and the DNA repair capacity were determined and values of relative biological effectiveness were compared.
Furthermore, the influence of radiation on the sphere formation was observed to examine the radiation response of
the potential fraction of stem like cells within the MCF10A cell population.
Results: X-rays and neutrons caused dose-dependent decreases of survival fractions after irradiations with up to
2 Gy. Monoenergetic neutrons with an energy of 0.56 MeV had a higher effectiveness on the survival fraction with
respect to neutrons with higher energies and to the mixed gamma - secondary neutron field induced by proton
interactions in water. Similar effects were observed for the DNA repair capacity after exposure to ionising radiation
(IR). Both experimental endpoints provided comparable values of the relative biological effectiveness. Significant
changes in the sphere formation were notable following the various radiation qualities.
Conclusion: The present study compared the radiation response of MCF10A cells after IR with neutrons and photons.
For the first time it was shown that monoenergetic neutrons with energies around 1 MeV have stronger radiobiological
effects on normal human breast cells with respect to X rays, to neutrons with a broad energy distribution (<En > = 5.
8 MeV), and to the mixed gamma - secondary neutron field given by interactions of 190 MeV protons in water. The
results of the present study are highly relevant for further investigations of radiation-induced carcinogenesis and are very
important in perspective for a better risk assessment after secondary neutron exposure in the field of conventional and
proton radiotherapy.
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Background
The incidence of carcinogenesis as a late effect of radio-
therapy is discussed in several studies as there is a grow-
ing number of long-term cancer survivors [1–5]. The
risk for the development of secondary malignant neo-
plasms is significantly increased, especially for breast
cancers among women who were irradiated as a treat-
ment for Hodgkin disease in childhood or adolescence
using particle proton therapy [6–9], which allows a bet-
ter dose conformation to the target volume than con-
ventional radiotherapy. Due to a production of
secondary neutrons during proton therapy (and also
during photon therapy with high energies), healthy tissue
distal to the target region can be exposed to neutrons
with a potentially high biological effectiveness [10]. Until
now, the potential for the induction of neoplasms fol-
lowing low-dose neutron exposures has not been very
well characterised.
The DNA can be considered as the most important
target of ionising radiation (IR), since misrepair of
radiation-induced DNA damage can be the initial step of
carcinogenesis. Hence, radiation-induced DNA double-
strand breaks (DSBs) were scored 24 h after exposure by
visualising and counting residual γH2AX foci, which are
considered as a reliable biomarker for the investigation
of complex DNA damage [11–13]. The clonogenic sur-
vival was determined after neutron and X-ray IR via col-
ony forming assays as a measure of long-term effects
and to classify the unknown biological effects of a clin-
ical relevant secondary neutron field into a defined
spectrum of different neutron energies. Using X-rays as
a reference, the observed radiation effects of neutrons
were compared using the concept of relative biological
effectiveness (RBE). Irradiations with low-energy monoe-
nergetic neutrons and medium-energy neutrons with a
broad energy distribution and a mean energy of about
5.8 MeV were performed. In order to generate a field of
secondary neutrons, similar to that produced during
proton therapy, a 190 MeV proton beam was directed
onto a water phantom.
In 2009, Stingl suggested that “normal stem and pro-
genitor cells are the likely targets for malignant trans-
formation” and have the ability to self-renew [14]. In
order to confirm the capacity of healthy mammary cells
to function as progenitor cells, and thus as an initial tar-
get for carcinogenesis, the present study investigated the
self-renewal potential of the MCF10A cells – a non-
transformed cell line with properties of progenitor cells
[15] – utilising a 3D spheres formation assay as de-
scribed in literature [14, 16]. Our study of these highly
relevant endpoints and measurements of RBE values for
neutron exposures will expand on the current know-
ledge: provided results are useful in perspective for the
assessment of the risk of cancer induction by IR, both
for radiation protection and for optimization in proton
and photon therapy, through the inclusion in treatment
planning of the risk evaluation for secondary cancer.
Methods
Cell culture
MCF10A (provided by Prof. Kevin Prise, Queen’s Uni-
versity Belfast, Ireland), is a spontaneously transformed
cell line from normal human mammary epithelial cells
[17], authenticated using STR typing (Additional file 1).
The cells were cultivated using Dulbecco’s modified
Eagle medium/F12 (DMEM/F12, Gibco/Life Technolo-
gies, Darmstadt, Germany) supplemented with 0.01%
cholera toxin, 0.1% insulin, 0.05% hydrocortisone and
1% penicillin/streptomycin (all Sigma Aldrich, Hamburg,
Germany), 0.02% epidermal growth factor (EGF; Gibco/
Life Technologies) and 5% horse serum (Fisher Scien-
tific, Schwerte, Germany) under 5% CO2 and at 37 °C.
The cells were passaged two times a week.
Irradiation setup
A homogenous irradiation for cells in a single cell suspen-
sion was ensured by using rotating systems. The first setup
consists in a ring holder with seven cylindrical containers
(1 ml volume, 3 mm thick, 20 mm in diameter), made of
polymethylmethacrylate (PMMA), positioned on a wooden
motor-driven rotator, which allowed a slow rotation to keep
the cells in suspension during the whole irradiation time.
This arrangement was used for the irradiations with X-rays,
medium-energy neutrons with a broad energy distribution
at Physikalisch-Technische Bundesanstalt (PTB, Braun-
schweig, Germany) and for the mixed gamma - secondary
neutron field at the KVI-Center for Advanced Radiation
Technology (KVI-CART, Groningen, The Netherlands),
where the radiation field was wide enough to perform
homogeneous irradiation of more containers at a time with
a single dose. For irradiations with low-energy monoener-
getic neutrons at PTB the same containers but a modified
rotator was used, on which three samples were placed in a
row at distances of 50, 70 and 100 mm from the neutron
source. This solution allowed to perform irradiation of
three containers at a time, each distance corresponding to a
different dose point.
Sham irradiated samples were used as negative control.
Afterwards the cells were seeded as an adherent culture.
As the reference, photon irradiations with X-rays were
performed at ambient temperature using an X-Strahl
200 system (Xstrahl Ltd., Surrey, United Kingdom) at
220 kV, filtered with 1 mm Al, 0.25 mm Cu and
0.45 mm Sn. The dosimetry is based on the German
Standard DIN 6809–5. The uncertainties are about ±3%.
In addition to irradiations at a high dose rate (HDR) of
0.37 Gy/min, a low dose rate (LDR) of 0.02 Gy/min was
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used to match the dose rate of the neutron irradiations.
Doses of 0.1, 0.25, 0.5, 1, 2, 4 and 6 Gy were used.
Two types of neutron irradiations were performed at
PTB: firstly, a “medium-energy” intense neutron field
with dose rates of 0.1 Gy/min (HDR) and of about
0.003 Gy/min (LDR). It was produced by the 9Be + d re-
action on a thick Be-target within a collimator at a deu-
teron energy of 13 MeV. The energy distribution is
broad and extends from about 0.1 to 10 MeV [18]. The
energy spectrum is shown in Fig. 1. The 0-degree, “free-
in-air”, tissue-kerma-averaged mean neutron energy is
<En > = 5.8 MeV [19] (for ionising radiation, kerma is
defined as the sum of the initial kinetic energies of all
charged particles liberated in a given mass of material by
the incident uncharged particles, divided by such mass;
the unit of kerma is Gy [20]). Dose to tissue was deter-
mined using a calibrated tissue-equivalent ionisation
chamber according to ICRU89 [21]. The relative stand-
ard uncertainty for the total dose determination was 6%.
The dose due to photon radiation was about 2.5%. Neu-
tron doses of 0.1, 0.25, 0.5, 1 and 2 Gy were applied.
Secondly, “low-energy” monoenergetic neutrons with
an energy of 1.2 MeV (0.003 Gy/min) were produced by
the T(p,n)3He reaction and neutrons of 0.56 MeV
(0.0045 Gy/min) by the 7Li(p,n)7Be reaction [22, 23].
Both energy spectra are shown in Fig. 1. The neutron
yield per unit target charge at an emission angle of 0°
was measured using a Long Counter. Monte Carlo neu-
tron transport calculations were carried out to deter-
mine the spectral neutron distribution in the liquid cell
suspensions from the 0° neutron yield and the known
angular distribution of neutron yield and neutron energy
at larger emission angles. The tissue kerma was calcu-
lated from the spectral fluence using the fluence-to-
kerma conversion coefficients [19]. In this way, the con-
tribution of neutrons scattered in the sample holder was
properly accounted for. The relative contributions of
scattered neutrons to the kerma and the kerma-
weighted mean energy of the scattered neutrons are
summarised in Table 1. The relative standard uncer-
tainty for the total dose determination was about 7%.
The dominant contribution resulted from the uncer-
tainty of the distance of the sample to the neutron
source. Cells were exposed to neutrons of 0.56 MeV with
doses of 0.16 Gy, 0.40 Gy and 0.84 Gy, and to neutrons
of 1.2 MeV with doses of 0.18, 0.42 and 0.85 Gy for col-
ony forming and γH2AX assay, as well as doses of
0.82 Gy (for 0.56 MeV) and 0.88 Gy (for 1.2 MeV) for
spheres formation assay.
In order to generate a neutron spectrum similar to
that produced during proton therapy, additional irradia-
tions were performed at the KVI-CART. An uncolli-
mated pencil beam of 190 MeV protons with a width
(1σ) of 4 mm and an RMS energy spread of about 0.2%
was directed onto a 300 mm cubic water phantom (with
front and back layers of 8 mm PMMA) in which the
protons were stopped. The beam profile at the entrance
of the phantom was measured with Gafchromic EBT
film. The proton current impinging on the water phan-
tom was monitored using an ionisation chamber which
a b
c d
Fig. 1 Relative energy distributions of the four different neutron fields. a Low-energy monoenergetic neutrons of 0.56 MeV; b Low-energy
monoenergetic neutrons of 1.2 MeV; c Medium-energy neutrons with a broad energy distribution and a mean neutron energy of <En > =
5.8 MeV; d Mixed gamma - secondary neutron field with a mean neutron energy of <En > = 70.5 MeV, produced by a 190 MeV proton beam
impinging on a water phantom
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was calibrated using a scintillation detector to determine
the number of protons as function of the accumulated
charge from the ionisation chamber. The absolute uncer-
tainty in the number of protons entering the water
phantom is estimated to be of the order of 1%. This un-
certainty is mainly due to the uncertainty in the deter-
mination of the calibration factor converting the
accumulated charge from the ionization chamber to the
number of protons entering the water phantom. Samples
were positioned behind the water phantom (at 0° relative
to the incident proton beam) at a distance of 50 mm.
Proton interactions in water generated a mixed gamma
– secondary neutron field at the sample positions. The
total dose on the sample delivered by the mixed field
was determined using a Monte Carlo simulation de-
scribed below to be 4.0E-15 Gy/proton. Four sets of
samples were irradiated with respectively 3.80E13;
9.50E13; 1.90E14 and 3.80E14 protons entering the
water phantom, with total doses of 0.152, 0.38, 0.76 and
1.52 Gy, respectively. The dose rate was chosen such
that each irradiation had equal duration (5.5 h), and that
such duration was comparable to that for LDR irradia-
tions at PTB, in view of the final data comparison. The
relative standard uncertainty for the total dose determin-
ation was about 5–6%.
All radiation fields and sample exposures were simu-
lated using the Monte Carlo radiation-transport code
PHITS ver. 2.88 [24], verifying dose homogeneity in the
containers, dose-distance relationships and characteristics
of the neutron/photon field at the container location. For
the irradiation setup at KVI-CART, the primary proton
beam source of energy 190 MeV was modelled as a Gauss-
ian distribution in x-y plane with full width at half max-
imum (FWHM) of 0.9 cm. The energy spectrum (Fig. 1)
of the secondary neutron field produced by a 190 MeV
proton beam impinging on a water phantom was simu-
lated exactly at the cell position. The dose-averaged mean
neutron energy at the cell position was calculated as
<En > =70.5 MeV. The ratio of neutron dose/total dose
was 0.65, meaning 35% extra dose to the samples from
gammas. This estimation of the neutron absorbed dose is
done by tracking the recoil particles directly, and running
PHITS in the mode that scores the energy loss of charged
particles and nuclei. For neutron induced reactions below
20 MeV, PHITS was run in the Event Generator Mode
using the Evaluated Nuclear Data libraries JENDL-4.0.
[25]. For higher energy neutrons (and for other hadrons),
the intra-nuclear cascade model INCL4.6 [26] was
employed for simulating the dynamic stage of hadron-
induced nuclear reactions. The quantum molecular dy-
namics model JQMD [27] was employed for nucleus-
induced reactions. The evaporation and fission model
GEM [28] was adopted for simulating the static stage for
both hadron- and nucleus-induced reactions.
Colony forming assay
Twenty-four hours after IR, 1 × 103 cells were seeded in
a 25 cm2 cell culture flask in triplicates for each dose
value. Eight days later the colonies were fixed with 70%
ethanol for 10 min and stained for 5–10 min with 1%
crystal violet solution (Serva Electrophoresis GmbH,
Heidelberg, Germany). Colonies consisting of 50 cells
and more were counted. Plating efficiency and survival
fractions (SF) were determined and RBE values for a sur-
vival of 10%, referred to as RBE(SF 0.1) in the text, were
calculated with respect to X-rays (LDR) as described by
Paganetti [29].
Immunostaining of DSBs via γH2AX antibody
Directly after irradiation, 1 × 104 cells per well (1.8 cm2)
were seeded in duplicate in chamber slides (LabTek®,
Nunc, Roskilde, Denmark) and incubated for 24 h. After
fixation with 2% formaldehyde and permeabilisation with
0.25% triton-X 100 (both Sigma Aldrich Chemie GmbH,
Munich, Germany) the cells were consecutively incubated
60 min with anti-γH2AX antibody (1:500, clone JBW301,
Merck Millipore) and Alexa Fluor 594 goat anti-mouse
IgG1 (1:400, Molecular Probes®/Life Technologies, Darm-
stadt, Germany) for 30 min. The slides were mounted with
Vectashield® containing anti-4′,6-diamidino-2-phenylin-
dole (DAPI; Vector Laboratories, Inc., Burlingame, CA).
The foci were visualised with an Eclipse TE300 inverted
microscope (Nikon, Tokyo, Japan). At a magnification of
1000×, the foci of 50 cells per chamber were counted; two
chambers per irradiation. The extra yield (ΔY) was calcu-
lated as the difference between irradiated samples and the
individual 0 Gy control value of residual foci as a function
of dose and plotted in a graph. Linearisation was per-
formed as described by Barendsen [30]. RBE values,
Table 1 Neutron contribution for 1.2 MeV and 0.56 MeV
monoenergetic neutrons
1.2 MeV
d/cm Ksc/Kdir <Edir>/MeV <Esc>/MeV <Etot>/MeV
5.27 0.127 1.190 0.821 1.149
7.27 0.226 1.195 0.842 1.130
10.27 0.253 1.197 0.881 1.134
0.56 MeV
d/cm Ksc/Kdir <Edir>/MeV <Esc>/MeV <Etot>/MeV
5.27 0.174 0.562 0.386 0.536
7.27 0.332 0.563 0.394 0.521
10.27 0.378 0.564 0.411 0.522
Relative contribution of scattered neutrons to the kerma K and the kerma-
weighted mean energies <E > of the scattered neutrons and direct for
1.2 MeV and 0.56 MeV monoenergetic neutrons. The subscripts ‘sc’ and
‘dir’ denote scattered and direct, i.e. uncollided, neutrons, respectively. The
distance of the centre of the volume containing the cell suspension from
the neutron source is denoted by d
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referred to as RBE(foci 24 h) in the text, were calculated with
respect to LDR X-rays via the α value with reference to
Franken et al. [31, 32]. Fits to the data points using the eq.
F(D) = αD + βD2 yielded β values of zero.
Sphere formation assay
Twenty four hour after IR 1 × 104 cells per well were
plated in triplicates in ultra-low attachment 6-well plates
(Corning® Costar®, Corning Incorporated, VWR, Darm-
stadt, Germany) for each irradiation dose. Since the cells
can not adhere to the cell culture surface, they are able to
form three-dimensional spheres. All samples were incu-
bated under standard cell culture conditions. The number
of spheres was counted by microscopy with a magnifica-
tion of 100× at day 1–7 after seeding, which is day 2–8
after IR. The sham irradiated control (0 Gy) of each radi-
ation quality was set to 100% at every counting day. The
radiation-induced change in the number of the spheres
was related to the appropriate 0 Gy control (100%).
Statistical analysis
Data of at least three independent experiments are rep-
resented as mean values ± standard error of the mean
(SEM). For the clonogenic survival and for DNA DSBs,
the assessment of statistical significance of differences
was performed by student t-test. The statistical analyses
of all values refer to LDR X-rays. The survival−/foci-
values obtained from fits to the data points were used
for statistical analyses between 0 and 2 Gy. A value of
p < 0.05 was considered to indicate a statistically signifi-
cant difference. F spheres formation, the statistical sig-
nificance to the individual sham-irradiated control
(0 Gy) of each radiation quality was calculated via one-
sample t-test and a value of p < 0.02 indicated a statisti-
cally significant difference.
Results
Clonogenic survival after IR
Long-term effects after radiation were investigated via the
clonogenic survival assay. For all radiation qualities a
dose-dependent decrease in the SF (Fig. 2) was observed.
Additional measurements up to 6 Gy were carried out for
X-rays in order to verify the linear-quadratic relation be-
tween dose and cell survival (Fig. 3). The SF after HDR X-
ray irradiation was about 67% after 1 Gy and 58% after
2 Gy; 1 Gy of X-rays LDR resulted only in a small decrease
of SF (78%). The strongest effects on the SF were observed
after irradiations with low-energy monoenergetic neutrons
of 0.56 MeV and 1.2 MeV. There were significant changes
for both monoenergetic neutron energies at 0.40 Gy (for
0.56 MeV neutrons) and 0.42 Gy (for 1.2 MeV neutrons),
respectively, as well as at 0.84 Gy and 0.85 Gy (0.56 MeV;
1.2 MeV) compared to the 1 Gy of LDR X-rays (SF of
78%). The effect of HDR < En > =5.8 MeV neutrons was
slightly less pronounced: after a dose of 1 Gy the SF was
35%. This effect was still significant compared to the sur-
vival after 1 Gy of LDR X-rays. With respect to 2 Gy of
HDR X-rays, the SF was significantly decreased by a factor
of 5 after 2 Gy of HDR medium-energy neutrons
(<En > =5.8 MeV). The effectiveness of 1 Gy of LDR
medium-energy neutrons was higher compared to X-ray
LDR as the SF was only 42%. The mixed gamma - second-
ary neutrons had a comparable effect on the cells as HDR
and LDR medium-energy neutrons (<En > =5.8 MeV).
After an IR of 1.52 Gy the SF was reduced to 20%. RBE
Fig. 2 Clonogenic survival of MCF10A cells after irradiation. Data from
three (LDR < En > = 5.8 MeV neutrons, HDR and LDR X-rays, mixed
gamma – secondary neutron <En > = 70.5 MeV field), four (HDR < En > =
5.8 MeV neutrons, 0.56 MeV monoenergetic neutrons), and five
(1.2 MeV monoenergetic neutrons) independent experiments, are
presented as mean values ± SEM of the survival fraction. The
significances refer to the equal doses of X-rays LDR irradiation.
Asterisks illustrate significances: *p < 0.05, **p < 0.01,
***p < 0.001. (HDR, high dose rate; LDR, low dose rate)
Fig. 3 Clonogenic survival of MCF10A cells after HDR X-rays. Data
from three independent experiments are presented as mean values
± SEM of the survival fraction. The significances refer to the 0 Gy
control of X-rays HDR. Asterisks illustrate significances: *p < 0.05,
**p < 0.01, ***p < 0.001. (HDR, high dose rate)
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values were calculated using 220 kV X-rays LDR as a ref-
erence (Table 2). Monoenergetic neutrons of 0.56 MeV
and 1.2 MeV had the highest RBE values of 4.97 and 3.75
respectively. The RBE value of 2.09 for the mixed gamma
- secondary neutrons (<En > = 70.5 MeV) is similar to
RBE values of 2.06 and 1.99 for HDR and LDR medium-
energy neutrons (<En > =5.8 MeV).
Residual γH2AX foci induction by IR
Radiation-induced residual γH2AX foci, used as markers
for complex DSBs, were detected 24 h following irradia-
tions, when repair of less complex lesions is supposed to
be completed and a higher complexity of residual lesions
can be assumed. The extra yield of foci was plotted with
respect to sham conditions of each radiation type. The
number of foci increased with higher doses for all radi-
ation qualities (Fig. 4). Increasing doses (HDR and LDR)
of 220 kV X-rays caused low but significant increases in
the mean number of DSBs within the cell nuclei. Monoe-
nergetic neutrons of 1.2 MeV as well as HDR and LDR
medium-energy neutrons produced much more damage
in terms of DSBs as LDR and HDR X-rays. The exposure
to a mixed gamma - neutron field with secondary neu-
trons of <En > = 70.5 MeV, as performed at KVI-CART,
induced an almost similar effect as HDR neutrons of
<En > = 5.8 MeV. The α-based RBE values for foci induc-
tion showed a very clear increase following neutron radi-
ation exposure with HDR and LDR medium-energy
neutrons, low-energy neutrons of 1.2 MeV and the mixed
gamma - secondary neutron field produced by a 190 MeV
proton beam, when compared to X-rays. The values were
even higher when the cells were irradiated with monoe-
nergetic neutrons of 0.56 MeV (Table 2).
Formation of spheres after IR
The influence of IR on the sphere formation ability of hu-
man mammary epithelial cells was examined using the
sphere formation assay. This assay was performed 24 h
after irradiation (Fig. 5). For low-energy neutrons and for
the mixed gamma – secondary neutron field the values for
the highest radiation dose (0.88 Gy for 1.2 MeV neutrons,
0.82 Gy for 0.56 MeV neutrons, 1.52 Gy for the mixed field)
and for medium-energy neutrons and X-rays the values for
1 Gy were normalized to the 0 Gy control, which was set to
100% for each day (see 100% baseline in the graph).
With respect to the individual 0 Gy control per day,
there is a general decrease of the sphere formation abil-
ity visible for every radiation quality. The irradiation
with LDR X-rays showed a clear reduction of the sphere
formation ability at day 2 and 4, unlike HDR-X-rays,
where no significant impairments could be observed.
The exposure to neutrons caused significant changes.
The use of HDR neutrons (<En > = 5.8 MeV) showed a
slightly stronger effect, especially on day 4, as the LDR
neutrons, which showed a uniform reduction at all days,
which is in the range of 63–73%. Radiation with 0.88 Gy
of 1.2 MeV monoenergetic neutrons and 1.52 Gy of a
mixed gamma-secondary neutron field showed time-
dependent a reducing effect on the sphere formation
ability. On the eighth day, the ability to form spheres is
more restricted than on the second day after irradiation.
In addition, the exposure to 0.56 MeV monoenergetic
neutrons resulted in a strong reduction of the sphere
formation ability already 2 days after irradiation but this
decrease seemed to recover within the following 6 days.
Discussion
In order to investigate the RBE of neutrons relative to
photons as a function of neutron energy, the present
study examined the different radiobiological effects fol-
lowing neutron and X-ray radiation. We also measured
the RBE of a mixed gamma - secondary neutron field,
generated by interactions of 190 MeV protons in water,
with a neutron dose equal to 65% of the total dose, and
neutrons with an energy spectrum similar to that pro-
duced in a clinical setting for proton therapy. Currently,
there are limited systematic studies on the effects of
neutron exposure as a function of neutron energy on
normal tissue cells, highlighting the comparison of neu-
trons to photons (an example in this sense is the study
by Göhde et al. with neutron energies of 0.56 MeV,
2.5 MeV and 14.8 MeV [33]).




of foci 24 h
RBE(SF 0.1) RBE(foci 24 h)
220 kV X-rays LDR, reference 0.12 0.84 1.00 1.00
220 kV X-rays HDR 0.24 1.87 0.58 2.22
<En > = 5.8 MeV neutrons LDR 0.43 4.43 2.06 5.25
<En > = 5.8 MeV neutrons HDR 0.65 3.86 1.99 4.57
1.2 MeV monoenergetic neutrons 1.91 3.36 3.75 3.98
0.56 MeV monoenergetic neutrons 2.55 6.71 4.97 7.95
mixed gamma – secondary neutron (<En > = 70.5 MeV) field 1.03 3.77 2.09 4.47
RBE(SF 0.1) are calculated for a survival fraction of 10%, RBE(foci 24 h) are α-based calculated according to F(D) = αD + βD
2, with β equal to zero [31, 32]
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Concerning clonogenic survival, our data showed a
large variation between the effects of various neutron
energies with regard to the use of doses up to 1 Gy. Pre-
sented results about the radiobiological effects on the
clonogenic survival with low-energy monoenergetic neu-
trons are of particular significance in contrast to X-rays
and medium-energy neutrons (<En > = 5.8 MeV). Com-
pared to X-rays (LDR), the SF was significantly de-
creased after irradiation with monoenergetic neutrons
(0.56 MeV, 1.2 MeV). This effectiveness of 0.56 MeV
neutrons on the clonogenic survival confirms the results
of Okumura et al. [34]. Frankenberg-Schwager et al. [22]
obtained an RBE of 5.4 for a different cell line, experi-
mental conditions and reference radiation quality. These
studies confirm and support our results on the effect of
neutrons, but lack the representation of human tissue
specific cells, using non-human or hybrid cell lines and
also a smaller range of applied doses. The present study
quantifies the long-term effects of neutrons with differ-
ent energies and doses on normal human tissue cells
from the mammary gland.
A common feature of our study and others [22, 34] is
the use of cell suspensions for the irradiation. A study in-
vestigating different cell culture models used during the ir-
radiation was led by Cansolino and colleagues [35]. Here,
the SF for cell suspension and adherent cells was deter-
mined for rat colon adenocarcinoma cell lines. In accord-
ance to our data, they showed a higher impact of neutrons
(up to 10 Gy) on suspended cells compared to 60Co.
Furthermore, next to energy, radiation type and doses,
the dose rate can play an important role for the radiobio-
logical effects, especially regarding the induction of residual
Fig. 4 DNA double-strand breaks 24 h after irradiation. Extra yield ΔY (difference over the individual 0 Gy control value) of residual γH2AX foci as
a function of dose scored in MCF10A cells 24 h after radiation. Data from three (mixed gamma – secondary neutron <En > = 70.5 MeV field and
X-rays) and four (medium-energy <En > = 5.8 MeV neutrons, 1.2 MeV and 0.56 MeV monoenergetic neutrons) independent experiments are
presented as mean values ± SEM. Fitted with LQ model F(D) = αD + βD2, with β equal to zero [30–32]. The significances refer to the equal doses
of X-rays LDR irradiation. Asterisks illustrate significances: *p < 0.05, ***p < 0.001. (HDR, high dose rate; LDR, low dose rate)
Fig. 5 Sphere formation after irradiation. Change of the sphere formation ability of MCF10A cells at different time points after exposure to X-rays
and neutrons with respect to individual 0 Gy control per day (=100% baseline). Data from three independent experiments are presented as mean
values ± SEM. Significances refer to the individual 0 Gy control of each radiation quality per day. Asterisks illustrate significances: *p < 0.02,
**p < 0.01, ***p < 0.002. (HDR, high dose rate; LDR, low dose rate)
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γH2AX foci. For DNA damage, represented by γH2AX foci
(DSBs) 24 h after radiation exposure, our findings reveal a
2-fold higher response of cells irradiated with HDR in con-
trast to LDR X-rays. This can be a result of repair processes,
which start after a few minutes. Therefore, DSBs induced
by LDR may already be partially repaired during the irradi-
ation process before the full applicable dose is reached, as
the time for a dose of 1 Gy generated with LDR is more
than 20-times longer than generated with HDR [36].
Our results demonstrated that the number of residual
γH2AX foci 24 h after IR, as an indicator for DSBs, in-
creased as a function of increasing dose, which has been
also reported by Okumura and colleagues [34], who ob-
served 53BP1 foci as an indicator for DSBs for several
time points. In contrast, they could not identify a differ-
ence between samples (1–3 h following IR) exposed to
neutrons (mixed beam) and γ-rays, however, they did
not examine the residual γH2AX foci 24 h after radi-
ation. Just as Tanaka et al. observed DNA damage by
means of comet assay [37], we could also demonstrate a
higher biological effectiveness of 0.56 MeV monoener-
getic neutrons compared to 1.2 MeV neutrons. Their
analysis of DNA damage demonstrated the same pattern
of effectiveness of the different radiation qualities.
Using a sphere formation assay, we examined the
radiation-induced response of a potential stem-like subpop-
ulation: it is known that MCF10A cells include a progenitor
like cell subpopulation [15]. Present data showed alterations
in the sphere formation ability, which were more evident
following monoenergetic neutron irradiation and following
the exposure to the mixed gamma - secondary neutron
field, compared to X-rays and medium-energy neutrons
(<En > = 5.8 MeV). Like Dionet et al., who investigated fast
neutrons on normal skin fibroblast by cell survival assay,
we could show a stronger effect following HDR neutrons
compared to LDR neutrons [38]. In general, most publica-
tions concerning sphere formation combining mammary
cells and radiation are dealing with cancer cell lines [39,
40]. The present study gives instead a first insight on the
sphere formation ability of normal human breast cells irra-
diated with a broad range of neutron energies.
From the presented dataset, observable differences in
RBE values by various neutron energies relative to X-
rays can be concluded.
Consistent with Tanaka et al. [37] and Schmid et al. [23],
we obtained results with increasing RBE values as a function
of decreasing neutron energies (between 0.56 MeV and
<En > = 5.8 MeV). The mixed gamma - secondary neutron
(<En > = 70.5 MeV) field, generated by protons of 190 MeV
impinging on a water phantom, yielded RBE values for both,
SF and residual foci, which are comparable to those of HDR
and LDR medium-energy neutrons of <En > = 5.8 MeV:
4.47 for RBE(foci 24 h) and 2.09 for RBE(SF 0.1). As well
known, RBE is a variable function of several factors, among
which the endpoint itself [37, 41]. Qualitative consistency is
found in this study between RBE(SF 0.1) and RBE(foci 24 h),
both increasing with decreasing neutron energies for the
covered range from 0.56 MeV to <En > = 5.8 MeV.
Conclusions
The present study extensively investigated chosen radio-
biological effects following exposures in the dose range of
0 Gy up to 2 Gy to different neutron energies compared
to X-rays in MCF10A normal human breast cells. The
range of selected neutron energies (0.56 MeV, 1.2 MeV
and a broad spectrum with a mean energy of 5.8 MeV)
was expanded by the use of a mixed gamma - secondary
neutron field (<En > = 70.5 MeV), adopted to simulate the
scattered neutron field during proton therapy. Dose-rate
effects were also addressed when high vs. low dose rate
exposures could be performed (X-rays and medium-
energy neutron exposure). Effects on clonogenic survival
and γH2AX residual foci induction are reported, which
were strongly dependent on radiation quality and dose
(dose rate for residual foci induction only). RBE values
were extracted from measured endpoints as RBE(SF 0.1)
and RBE(foci 24 h). They are found to be coherently increas-
ing for decreasing neutron energy in the investigated en-
ergy range. The exposure to the mixed gamma -
secondary neutron field yield RBEs as high as for
medium-energy neutrons. The response of the potential
fraction of stem-like cells in the MCF10A cell population
was also addressed, by measuring sphere formation ability
for up to 8 days after exposure with the maximal dose or
1 Gy for each radiation quality (0.88 Gy – 1.52 Gy).This
investigation provides a deeper insight into the radiobio-
logical effects of neutron exposure, which is very import-
ant in order to assess the risk of secondary neutrons
produced during conventional and particle radiotherapy
and their possible trigger function for potential carcino-
genic effects on normal breast cells and stem cells.
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